Antihypertensive Therapy: Compliance and Quality of Life

  • Gordon H. Williams
Part of the Atlas of Heart Diseases book series (AD)


Health-related quality of life (QOL) refers to the ability of an individual to perform in a number of roles in society and to reach an acceptable level of satisfaction from functioning in these roles. A comprehensive and universal definition of QOL is difficult to achieve, probably because the precise elements for evaluating QOL vary under different circumstances and in different individuals. Furthermore, the definition of a “good” QOL may vary depending on the culture, age, gender, and personal preference of the individual.


Antihypertensive Therapy Hypertension Detection Medical Research Council Working Party Gastrointestinal Therapeutic System Health Insurance Study 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Grimm RH Jr, Grandits GA, Cutler JA, et al.: Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. Arch Intern Med 1997, 157: 638–648.PubMedCrossRefGoogle Scholar
  2. 2.
    Hypertension Detection and Follow-Up Program Cooperative Group: Five-year findings of the Hypertension Detection and Follow-Up Program. I: Reduction in mortality in persons with high blood pressure. JAMA 1979, 242: 2562–2577.CrossRefGoogle Scholar
  3. 3.
    Hypertension Detection and Follow-Up Program Cooperative Group: The effects of treatment on mortality in “mild” hypertension: results of the Hypertension Detection and Follow-Up Program. N Engl J Med 1982, 307: 976–980.CrossRefGoogle Scholar
  4. 4.
    Medical Research Council Working Party on Mild-to-Moderate Hypertension: Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet 1981, ii: 539–544.Google Scholar
  5. 5.
    Kitler ME: The changing face of hypertension and antihypertensive agents. Drugs Aging 1996, 8: 5–11.PubMedCrossRefGoogle Scholar
  6. 6.
    Jachuck SJ, Brierley H, Jachuck S, et al.: The effect of hypotensive drugs on the quality of life. J R Coll Gen Pract 1982, 32: 103–105.PubMedGoogle Scholar
  7. 7.
    The Fifth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Bethesda, MD: National Institutes of Health; 1993: 93–1088.Google Scholar
  8. 8.
    Roberts J: Blood pressure of persons 18-74 years, United States, 1971-72. Data from the National Health Survey, Washington, DC: National Center for Health Statistics, 1975; DHEW publication no. 75-1632. (Vital and health statistics; series 11, no. 150).Google Scholar
  9. 9.
    Rowland M, Roberts J: Blood pressure levels and hypertension in persons ages 6–74 years: United States, 1976-80. Hyattsville, MD: National Center for Health Statistics, October 1982; DHHS publication no. 82-1250. (Advance data from vital and health statistics; no. 84).Google Scholar
  10. 10.
    Haynes RB, Sackett DL, Taylor DW, et al.: Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med 1978, 299: 741–744.PubMedCrossRefGoogle Scholar
  11. 11.
    Williams GH: Quality of life and its impact on hypertensive patients. Am J Med 1987, 82: 98–105.PubMedCrossRefGoogle Scholar
  12. 12.
    Spilker B, ed: Quality of Life Assessments in Clinical Trials. New York: Raven Press; 1990.Google Scholar
  13. 13.
    Fava GA, Magnani B: Quality of life: a review of contemporary confusion. Med Sci Res 1988, 16: 1051–1054.Google Scholar
  14. 14.
    Hollenberg NK, Testa M, Williams GH: Quality of life as a therapeutic end-point. Drug Safety 1991, 6: 83–93.PubMedCrossRefGoogle Scholar
  15. 15.
    Williams GH, Testa MA: Quality of life: an important consideration in antihypertensive therapy. In Management of Hypertension: A Multifactorial Approach. Edited by Hollenberg NK. Boston: Scientific Therapeutics Information, Inc.; 1987: 79–100.Google Scholar
  16. 16.
    Levine S, Croog SH: What constitutes quality of life? A conceptualization of the dimensions of life quality in healthy populations and patients with cardiovascular disease. In Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. Edited by Wenger NK, Mattson ME, Furberg CD, et al. New York: LeJacq; 1984: 46–58.Google Scholar
  17. 17.
    Bulpitt CJ, Dollery CT, Carne S: Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J 1976; 38: 121–128.PubMedCrossRefGoogle Scholar
  18. 18.
    Ware JE Jr, Johnston SA, Davies-Avery A, et al.: Conceptualization and Measurement of Health for Adults in the Health Insurance Study. Vol III: Mental Health. Santa Monica: Rand Corporation; 1979.Google Scholar
  19. 19.
    Brook RH, Ware JE Jr, Davies-Avery A, et al.: Conceptualization and Measurement of Health for Adults in the Health Insurance Study. Vol VIII: Overview. Santa Monica: Rand Corporation; 1979.Google Scholar
  20. 20.
    Ware JE Jr, Johnston SA, Davies-Avery A, et al.: Conceptualization and Measurement of Health for Adults in the Health Insurance Study. Vol I: Model of Health and Methodology. Santa Monica: Rand Corporation; 1980.Google Scholar
  21. 21.
    Hogan MJ, Wallin JD, Baer RM: Antihypertensive therapy and male sexual dysfunction. Psychosomatics 1980, 21: 234–237.PubMedGoogle Scholar
  22. 22.
    House JS: Work Stress and Social Support. Reading, MA: Addison-Wesley; 1981.Google Scholar
  23. 23.
    Croog SH, Levine S: Life After a Heart Attack: Social and Psychological Factors Eight Years Later. New York: Human Sciences Press; 1982.Google Scholar
  24. 24.
    Campbell A, Converse PE, Rodgers WL: The Quality of American Life. New York: Russell Sage Foundation; 1976.Google Scholar
  25. 25.
    Croog SH, Levine S, Testa MA, et al.: The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986, 314: 1657–1664.PubMedCrossRefGoogle Scholar
  26. 26.
    Williams GH, Croog SH, Levine S, et al.: Impact of antihypertensive therapy on quality of life: effect of hydrochlorothiazide. J Hypertens 1987, 5: S29–S35.CrossRefGoogle Scholar
  27. 27.
    Beto JA, Bansal VK: Quality of life in treatment of hypertension: a meta-analysis of clinical trials. Am J Hypertens 1992, 5: 125–133.PubMedGoogle Scholar
  28. 28.
    Guyatt GH, Van Zanten SJPV, Feeny DH, et al.: Measuring quality of life in clinical trials: a taxonomy and review. Can Med Assoc J 1989, 140: 1441–1448.Google Scholar
  29. 29.
    Testa MA, Hollenberg NK, Andersen RB, et al.: Assessment of quality of life by patient and spouse during antihypertensive therapy with atenolol and nifedipine gastrointestinal therapeutic system. Am J Hypertens 1991, 4: 363–373.PubMedGoogle Scholar
  30. 30.
    Testa MA, Anderson RA, Nackley JF, et al.: Quality of life and antihypertensive therapy in men: a comparison of Captopril with enalapril. N Engl J Med 1993, 328: 907–913.PubMedCrossRefGoogle Scholar
  31. 31.
    Anderson RB: What does it mean?:anchoring psychosocial quality of life score changes with reference to concurrent changes in reported symptom distress. Drug Inf J 1999, 33: 445–453.CrossRefGoogle Scholar
  32. 32.
    Anderson RB, Hollenberg NK, Williams GH: Physical Symptoms Distress Index:a sensitive tool to evaluate the impact of pharmacological agents on quality of life. Arch Intern Med 1999, Apr 12;159(7): 693–700.PubMedCrossRefGoogle Scholar
  33. 33.
    Weir MR, Prisant LM, Papademetriou V, et al.: Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events, and prior antihypertensive therapy. Am J Hypertens 1996, 9: 854–859.PubMedCrossRefGoogle Scholar
  34. 34.
    Holmes TH, Rahe RH: The Social Readjustment Rating Scale. J Psychsom Res 1967, 11: 213–218.CrossRefGoogle Scholar
  35. 35.
    Wilson TW, Chockalingam A, Quest DW: Pharmacoeconomics of hypertension control: basic principles of economic evaluation. J Hum Hypertens 1996, 10(suppl 2): 19–22.Google Scholar
  36. 36.
    Menard J: Cost-effectiveness of hypertension treatment. Clin Exp Hypertens 1996, 18: 399–413.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Gordon H. Williams

There are no affiliations available

Personalised recommendations